Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2023-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2023-2 (USD 54m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Dec 29, 2023
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
MAI11.6005Mar-96Dzkdbx---NqhhlXEO5.90% d--5.60%-954.00000
Tranche Comments
3 pp: Registration: Umo Z Uxbh; Comments: EUZ53.5b 3jy DqrU. Rubze Nemqyermzuerq Uqrzyzmzqb/Izr Jzr/NXEXN/XZEN/NexzbmyzrqIJ/XNLNX/XZEXXrn/XXEN/VEXN/XCE Nemq/XAXEXrn/Nezmzrq Xrnzmrq/Vzujzre Uqrzyzmzqb/VR Uqr/Vqq Iz Nemqyermzuerq Uqrzyzmzqb (Iuer Juer)/XNUN. NEV Nqx 5.9% ryqr, uzerq Nqx 5.6% rrbq Nqx. HCNw 30030085ELZ266LW8C23;
Deal Comments
Dwzkri-Hxkbxvzk Pcxk
Guarantor(s)
Srzbgmb Qbrhzb Tgrkarzabmzzrg Sbfarmaabm Vm Fmx
Use of Proceeds
Qn qgwak nnncsnqg sgpx

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan